Amyloidosis Clinical Trials in St Louis, Missouri

3 studies are recruiting for amyloidosis in St Louis, Missouri right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant

    Transthyretin amyloidosis (ATTR) is a disease where the normally occurring transthyretin (TTR) protein falls apart and forms amyloid, a sticky plaque-like substance that accumulates in different organs in the body and can cause damage to the organ. There are two ways that the TTR protein can fall a…

    Stage
    Phase 3
    Ages
    18 to 75
    Site
    Washington University in St. Louis, St Louis, Missouri
    Locations
    104 in total
    Run by
    Eidos Therapeutics, a BridgeBio company

    See if you can join NCT06563895 on ClinicalTrials.gov

  2. Cardiac Magnetic Resonance and Echocardiography Study With Acoramidis

    The study aims to evaluate the effect of acoramidis on cardiac functional and structural improvement in participants with ATTR-CM.

    Stage
    Phase 4
    Ages
    18 to 80
    Site
    Washington University in St. Louis, St Louis, Missouri
    Run by
    Eidos Therapeutics, a BridgeBio company

    See if you can join NCT07695701 on ClinicalTrials.gov

  3. A Phase 1b/2 Study of CAR T Cell Therapy Targeting CD19 and BCMA in Participants With Relapsed or Refractory AL Amyloidosis.

    Open-label Phase 1b/2 study with primary objective of this study is to evaluate the safety, tolerability and efficacy of AZD0120 in participants with light chain (AL) amyloidosis.

    Stage
    Phase 1
    Ages
    18 and older
    Site
    Research Site, St Louis, Missouri
    Locations
    18 in total
    Run by
    Alexion Pharmaceuticals, Inc.

    See if you can join NCT07081646 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.